Results of a real-world study on vortioxetine in patients with major depressive disorder in South East Asia (REVIDA).

CONCLUSION: In real-world clinical settings, vortioxetine was effective in reducing depression severity and improving cognitive function and work productivity in SEA patients with major depression. PMID: 29768955 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research